Ultragenyx Pharmaceutical (RARE) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.24% |
| Dec 31, 2025 | 27.12% |
| Sep 30, 2025 | 38.66% |
| Mar 31, 2025 | 40.53% |
| Dec 31, 2024 | 43.09% |
| Sep 30, 2024 | 53.59% |
| Jun 30, 2024 | 61.56% |
| Mar 31, 2024 | 67.39% |
| Dec 31, 2023 | 70.70% |
| Sep 30, 2023 | 71.81% |
| Jun 30, 2023 | 69.17% |
| Mar 31, 2023 | 67.89% |
| Dec 31, 2022 | 64.08% |
| Sep 30, 2022 | 71.03% |
| Jun 30, 2022 | 66.10% |
| Mar 31, 2022 | 60.71% |
| Dec 31, 2021 | 52.62% |
| Sep 30, 2021 | 45.55% |
| Jun 30, 2021 | 43.72% |
| Mar 31, 2021 | 45.52% |
| Dec 31, 2020 | 58.40% |
| Sep 30, 2020 | 50.65% |
| Mar 31, 2020 | 68.40% |
| Dec 31, 2019 | 71.00% |
| Sep 30, 2019 | 64.82% |
| Jun 30, 2019 | 58.93% |
| Mar 31, 2019 | 64.94% |
| Dec 31, 2018 | 72.17% |